)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Eckert & Ziegler
Eckert & Ziegler (EUZ) investor relations material
Eckert & Ziegler Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary26 Mar, 2026
Executive summary
Achieved record revenue exceeding €300 million in 2025, with strong growth in the Medical segment and stable gross margins despite challenges in H1 and a cyber incident affecting Isotope Products.
EBIT adjusted rose 18% year-over-year to €77.7 million, with net income up 47% to €48.8 million (EPS: €0.78).
Radiopharmaceuticals grew 16% year-over-year, driven by GalliaPharm, contract manufacturing, and licensing deals.
Long-term agreements and strategic partnerships, including with Novartis, Actinium Pharmaceuticals, and Bicycle Therapeutics, secured future business opportunities.
Financial highlights
Revenue: €312.0 million (+5% year-over-year, FX adjusted +7%).
EBIT adjusted: €77.7 million (+18% year-over-year).
Net income: €48.8 million (+47% year-over-year).
Free cash flow margin: 10% (down from 23% in 2024).
Equity ratio: 55% (up from 51% in 2024).
ROCE: 20% (up from 13% in 2024).
Outlook and guidance
2026 guidance: Revenue €320 million (+3%), EBIT adjusted €80 million (+3%).
Medical EBIT expected to decrease by 4%, Isotope Products EBIT to increase by 17%.
Adjusted for FX and license deals, underlying growth projected at 9% for revenue and 21% for EBIT adjusted.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Eckert & Ziegler
- Net income up 28% to €29.9M, Medical segment drives growth, 2025 outlook reaffirmed.EUZ
Q3 202517 Feb 2026 - Record revenue and EBIT growth driven by radiopharma and medical segments, with strong 2024 outlook.EUZQ4 20243 Feb 2026
- Radiopharmaceuticals and gallium generators fueled double-digit growth and global expansion.EUZGerman Equity Forum 20252 Feb 2026
- Revenue up 23%, EBIT up 44%, and 2024 profit guidance raised to €55M.EUZQ2 20241 Feb 2026
- Medical segment drives growth as radiopharmaceuticals expand and 2025 outlook stays positive.EUZIV. ICF Bank Small-/MidCap-Conference Presentation26 Jan 2026
- Strong medical and isotope growth, global expansion, and innovation drive future outlook.EUZ44th Annual J.P. Morgan Healthcare Conference15 Jan 2026
- Q1 2025 net profit up 14% with strong Medical margins and guidance reaffirmed.EUZQ1 202526 Nov 2025
- Net income rose 19% and Medical segment margins improved, supporting a positive 2025 outlook.EUZQ2 202518 Aug 2025
- Revenue and profit surged, with strategic spin-off and new contracts fueling future growth.EUZQ3 202413 Jun 2025
Next Eckert & Ziegler earnings date
Q1 202612 May, 2026
Eckert & Ziegler
Next Eckert & Ziegler earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage